Clinical trials
Completed COVID-19 trials in Kazakhstan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 4 |
| 2021 | 5 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Karaganda Medical University | 3 |
| Research Institute for Biological Safety Problems | 3 |
| Astana Medical University | 2 |
| Asfendiyarov Kazakh National Medical University | 1 |
| Catalysis SL | 1 |
| University Medical Center, Kazakhstan | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 11 |
| Severe Acute Respiratory Syndrome | 3 |
| Coronavirus Infections | 2 |
| Cognitive Dysfunction | 1 |
| Coinfection | 1 |
| Influenza, Human | 1 |
| Noncommunicable Diseases | 1 |
| Respiratory Tract Infections | 1 |
| Virus Diseases | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.